QualityStocksNewsBreaks Archives - Page 642 of 1452

WednesdayJul 28, 2021 2:23 pm

QualityStocksNewsBreaks – Avricore Health Inc. (TSX.V: AVCR) (OTC: AVCRF) Partners with Ellerca Health to Provide Enhanced Diabetes Screening, Management Support

Avricore Health (TSX.V: AVCR) (OTC: AVCRF), a pharmacy service innovator focused on acquiring and developing early-stage technologies aimed at moving pharmacy forward, has signed a partnership agreement with Ellerca Health Corp. The partnership is designed to leverage the two companies’ respective technologies and services in order to provide the most compelling diabetes screening and management solutions available for community pharmacy. Avricore’s focus is to make actionable health information more available by creating the largest rapid-testing network in pharmacy through its proprietary HealthTab(TM), a turnkey point-of-care testing solution that enables pharmacies to operate as diagnostic hubs, or community diagnostic centers, that connects them…

WednesdayJul 28, 2021 1:38 pm

QualityStocksNewsBreaks – BevCanna Enterprises Inc.’s (CSE: BEV) (OTCQB: BVNNF) (FSE:7BC) Naturo Group Awarded Contract with BC Wildfire Service

BevCanna Enterprises (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) today announced that its wholly owned subsidiary, Naturo Group, has been selected by the British Columbia Ministry of Forests, Lands, Natural Resource Operations and Rural Development, and has commenced manufacturing and delivery of a Special Limited Edition TRACE-branded white-label water for the Ministry’s Wildfire Services Division. “We’re pleased that we’ve been awarded the contract with BC Wildfire Service,” said Melise Panetta, president of BevCanna. “We are proud to be providing the firefighters with a special edition of our TRACE-branded natural 7.7ph alkaline spring water, sourced directly from our proprietary B.C. Interior aquifer…

WednesdayJul 28, 2021 1:19 pm

QualityStocksNewsBreaks– FingerMotion Inc. (FNGR) Announces Application to List Common Stock on Nasdaq Capital Market

FingerMotion (OTCQX: FNGR), a mobile data and services company, has submitted its application to have shares of its common stock listed on Nasdaq Capital Market. The company will now look to receive NASDAQ approval of the move as well as work to satisfy applicable listing, governance and regulatory requirements. During the NASDAQ review process, the company's common stock will continue to trade on the OTCQX using the current symbol FNGR. “Over the past year, we have been working diligently to comply with certain uplisting requirements," said FingerMotion CEO Martin Shen in the press release. "Applying for a NASDAQ listing is…

WednesdayJul 28, 2021 1:05 pm

QualityStocksNewsBreaks – PlantX Life Inc. (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) Announces Plans for Meal Delivery Service in the US

PlantX Life (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) has launched its meal delivery service in the United States, beginning initially in Southern California, with plans to expand. Called XFood, the service offers an exclusive variety of innovative plant-based meals designed by renowned vegan chef and PlantX culinary chief officer Matthew Kenney. According to the announcement, the program offers customers three-day meal plans that include six à la carte lunch and dinner meal options, as well as six cold-pressed juices from PLTXF’s recently acquired juice company, Little West. Customers can choose preferred items from a diverse, delicious list of vegan recipes; meals can…

WednesdayJul 28, 2021 12:40 pm

QualityStocksNewsBreaks – Golden Triangle Ventures Inc. (GTVH) Announces Plans to Acquire Le Pragma LLC

Golden Triangle Ventures (OTC: GTVH) (“GTV”), a multifaceted consulting company pursuing ventures across health, entertainment and technology industries, today announced its entry into a letter of intent (“LOI”) to acquire Le Pragma LLC. Comprised of a full retail line of all-natural, high-end health, wellness and beauty products, Le Pragma has a strategic vision of becoming the CBD line of the future. Le Pragma leverages cutting-edge formulations and dedication to a precise science to deliver optimal wellness throughout its quality product line. “Our team has worked very hard to formalize a strong plan to push sales, strengthen the products involved and…

WednesdayJul 28, 2021 12:09 pm

QualityStocksNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Eyes Clear Opportunity to Bring Impactful Therapy to GBM Patients

CNS Pharmaceuticals (NASDAQ: CNSP) is a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system. Over recent months, the company has achieved several milestones demonstrating its operational, financial and strategic strengths and continuous de-risking of its lead candidate Berubicin clinical program. “The company has begun a pivotal Phase 2 clinical trial evaluating the efficacy and safety of Berubicin for recurrent adult glioblastoma multiforme (‘GBM’). Enrollment in the clinical trial is already underway, with patient dosing set to begin in Q3 2021,” reports an article discussing the status of…

WednesdayJul 28, 2021 11:58 am

QualityStocksNewsBreaks – Nextech AR Solutions Corp. (OTCQB: NEXCF) (NEO: NTAR) (CSE: NTAR) (FSE: N29) to Release Q2 2021 Earnings, Schedules Earnings Call

Nextech AR Solutions (OTCQB: NEXCF) (NEO: NTAR) (CSE: NTAR) (FSE: N29), a diversified leading provider of augmented reality (“AR”) solutions and services, has announced plans to release its second-quarter 2021 financial results on Aug. 11, 2021, after markets close. The company will also host a conference call to discuss its financial numbers and results on Aug. 12 , 2021, at 1 p.m. ET. Nextech CEO Evan Gappelberg and CFO Andrew Chan will host the call and provide an overview of company financial and operating results; the call will also include a question-and-answer period. Interested individuals can call in toll-free by dialing…

WednesdayJul 28, 2021 11:09 am

QualityStocksNewsBreaks – Excellon Resources Inc. (TSX: EXN) (NYSE American: EXN) (FSE: E4X2) Announces Progress of Silver City Drilling Program

Excellon Resources (TSX: EXN) (NYSE American: EXN) (FSE: E4X2) today provided an update on the ongoing drilling program at the Silver City Project located in Saxony, Germany. Among the highlights, the company reported smooth commencement of drilling at the first of four priority targets of the 12,000-metre diamond drilling program planned for 2021. In addition, a second drill rig was added to the program, with drilling now underway at the Peter Vein (Neue Hoffnung Gottes) and Bräunsdorf (Christbescherung) targets. “We have had another smooth startup of drilling at Silver City this year,” said Ben Pullinger, SVP Geology & Corporate Development.…

WednesdayJul 28, 2021 10:51 am

QualityStocksNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Reaches Milestone in Human Clinical Study, Notes Growing Availability of DehydraTECH-Enabled Products

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug-delivery platforms, has reached a significant point in its second human clinical study of 2021: HYPER-H21-2. The company announced that dosing has been completed in the study, which was comprised of 16 human volunteers who were pre- or mildly hypertensive; each participant received three separate doses of 150 mg each of DehydraTECH(TM) 2.0-enabled CBD versus a placebo. The study also included 24-hour continuous monitoring of blood pressure and heart rate, as well as evaluations of central arterial stiffness, physical activity and sleep quality. This key information will be assessed to evaluate the…

WednesdayJul 28, 2021 10:43 am

QualityStocksNewsBreaks – XPhyto Therapeutics Corp.’s (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) Acquisition Target Identifies Breakthrough COVID-19 Detection Biosensor Candidates

XPhyto Therapeutics (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT), a life sciences technology accelerator, today announced that its acquisition target, 3a-diagnostics GmbH (“3a”), has identified the first saliva activated “in-mouth” biosensor candidates for the detection of a COVID-19 infection. According to the update, the enzyme-activated biosensors are developed for real-time, low-cost and easy-to-use oral screening applications for the rapid detection of infectious diseases including COVID-19 at home or at the point-of-care. “We believed in 3a’s research and development plan from the beginning, when we signed the first collaboration contract in 2020. Now that XPhyto has announced the pending acquisition of 3a,…

Site Search

Company Search

Category: QualityStocksNewsBreaks